Anabolic steroid-induced hepatotoxicity: Is it overstated?

Clinical Journal of Sport Medicine

Volumn 9, Issue 1, 1999, Pages 34-39

  Dickerman, Rob D ^a   Pertusi, Raymond M ^b   Zachariah, Nannepaga Y ^a   Dufour, D Robert ^c   McConathy, Walter J ^a,b  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^b University of North Texas Health Science Center   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Aminotransferases; Androgens; Bodybuilders; Exercise; Gamma glutamyltranspeptidase; Hepatitis; Muscle; Rhabdomyolysis; Steroid abuse

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ANABOLIC AGENT; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CHEMISTRY; BODY BUILDING; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION FUNCTION; CREATINE KINASE BLOOD LEVEL; ENZYME ASSAY; EXERCISE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATITIS; HUMAN; HUMAN CELL; LIVER DYSFUNCTION; LIVER TOXICITY; MALE; MEDICAL STUDENT; PRIORITY JOURNAL; TRAINING;

EID: 0032776570     PISSN: 1050642X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042752-199901000-00007     Document Type: Article

References (37)

1. Griggs RC, Kingston W, Jozefowicz RF, Herr BE, Forbes G, Halliday D. Effect of testosterone on muscle mass and muscle protein synthesis. J Appl Physiol 1989;66:498-503.
2. Dickerman RD, McConathy WJ, Schaller F, Prather I. Sudden cardiac death in a 20 year-old bodybuilder using anabolic steroids. Cardiology 1995;86:172-173.
3. Dickerman RD, McConathy WJ, Schaller F, Zachariah NY. Cardiovascular complications and anabolic steroids (letter). Eur Heart J 1996;17:1912.
4. Westaby D, Portmann B, Williams R. Androgen related primary hepatic tumors in non-Fanconi patients. Cancer 1983;51:1947-1952.
5. Appell HJ, Heller-Umpfenbach B, Feraudi M, Weicker H. Ultrastructural and morphometric investigations on the effects of training and administration of anabolic steroids on the myocardium of guinea pigs. Int J Sports Med 1983;4:268-274.
6. Bagheri SA, Boyer JL. Peliosis hepatitis associated with androgenic anabolic steroid therapy. Ann Intern Med 1974;81:610-618.
7. Bird DR, Vowles KDJ. Liver damage from long-term methyltestosterone. Lancet 1977;2:400-401.
8. Erlinger S. Drug-induced cholestasis. J Hepatol 1997;26(Suppl 1):1-4.
9. Johnson FL. The association of oral androgenic-anabolic steroids in life threatening disease. Med Sci Sports 1975;7:284-286.
10. Murphy P. Steroids: not just for athletes any more (letter). Physician Sportsmed 1986;14:48.
11. Wilson JD, Griffin JE. The use and misuse of androgens. Metabolism 1980;29:1278-1295.
12. Alen M. Androgenic steroid effects on liver and red cells. Br J Sports Med 1985;19:15-20.
13. Goldman B. Steroids and Sports. South Bend, IN: Icarus Press, 1984.
14. Kiraly CL. Androgenic-anabolic steroid effects on serum and skin surface lipids, on red cells, and on liver enzymes. Int J Sports Med 1988;9:249-252.
15. Lamb DR. Anabolic steroids in athletics: how well did they work and how dangerous are they? Am J Sports Med 1984;12:31-38.
16. Lenders JM, Demacker PM, Vos J, Jansen PL, Hoitsma AJ, van't Laar A, Thein T. Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur body-builders. Int J Sports Med 1988;9:19-23.
17. Manore MM, Thompson J, Russo M. Diet and exercise strategies of a world-class bodybuilder. Int J Sport Nutr 1993;3:76-86.
18. O'Connor JS, Baldini FD, Skinner JS, Einstein M. Blood chemistry of current and previous anabolic steroid users. Military Med 1990;155:72-75.
19. Taylor WN. Anabolic Steroids and the Athlete. London: McFarland, 1982.
20. Sweeney EC, Evans DJ. Hepatic lesions in patients treated with synthetic anabolic steroids. J Clin Pathol 1976;29:626-633.
21. Hakkinen K, Alen M. Training volume, androgen use and serum creatine kinase activity. Br J Sports Med 1989;23:188-189.
22. Janssen GME, Kuipers H, Keizer H, Verstappen F. Plasma enzyme activities and running performance in a maximal treadmill test before and after 30 Km race or marathon. Int J Sports Med 1984; 5:98-99.
23. Janssen GME, Kuipers H, Willems GM, Does RJ, Janssen MPE, Geurten P. Plasma activity of muscle enzymes: quantification of skeletal muscle damage and relationships with metabolic variables. Int J Sports Med 1989;10:S160-S168.
24. Dickerman RD, Schaller F, Zachariah NY, McConathy WJ. Left ventricular size and function in elite bodybuilders using anabolic steroids. Clin J Sport Med 1997;7:90-93.
25. Kayashima S, Ohno H, Fujioka T, Taniguchi N, Nagata N. Leucocytosis as a marker of organ specific damage induced by chronic strenuous physical exercise. Eur J App Physiol 1995;70:413-420.
26. Bernstein MS, Hunter RL, Yachnin S. Hepatoma and peliosis hepatitis developing in a patient with Fanconi's anemia. N Engl J Med 1971;284:1135-1136.
27. Wright JE. Anabolic steroids and athletics. Exercise Sport Sci 1980;8:149-202.
28. Westaby D, Ogle SJ, Paradinas FJ. Liver damage from long-term methyltestosterone. Lancet 1977;2:261-263.
29. Grover JR. Alcoholic liver disease. Emerg Med Clin North Am 1990;8:887-902.
30. Saunders JB. Treatment of alcoholic liver disease. Baillieres Clin Gastroenterol 1989;3:39-65.
31. Hartgens F, Kuipers H, Wijnen J, Keizer H. Body composition, cardiovascular risk factors and liver function in long term androgenic-anabolic steroid using bodybuilders three months after drug withdrawal. Int J Sports Med 1996;17:429-433.
32. Sheffer AL, Fearon DT, Austen KF. Clinical and biochemical effects of stanozolol therapy for hereditary angioedema. J Allergy Clin Immunol 1981;68:181-187.
33. Spaulding WB. Myalgia and elevated creatine phosphokinase with danazol in hereditary angioedema (letter). Ann Intern Med 1979; 90:854.
34. Koutedakis Y, Raafat A. Serum enzyme activities in individuals with different levels of physical fitness. J Sports Med Physical Fitness 1993;33:252-257.
35. Mena P, Maynar M, Campillo JE. Changes in plasma enzyme activities in professional racing cyclists. Br J Sports Med 1996;30: 122-124.
36. Bolgiano EB. Acute rhabdomyolysis due to body building exercise: report of a case. J Sports Physical Fitness 1994;34:76-78.
37. Hamer R. When exercise goes awry: exertional rhabdomyolysis. Southern Med J 1997;90:548-551.